Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126255871 | 12625587 | 1 | I | 2016 | 20160418 | 20160805 | 20160805 | EXP | JP-GLAXOSMITHKLINE-JP2016JPN053967 | GLAXOSMITHKLINE | 78.33 | YR | M | Y | 59.00000 | KG | 20160805 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126255871 | 12625587 | 1 | PS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 25 MG, QOD | Y | 20241 | 25 | MG | TABLET | QOD | |||||
| 126255871 | 12625587 | 2 | SS | LAMICTAL | LAMOTRIGINE | 1 | Oral | 100 MG, QD | Y | 20241 | 100 | MG | TABLET | QD | |||||
| 126255871 | 12625587 | 3 | C | TEGRETOL | CARBAMAZEPINE | 1 | 0 | ||||||||||||
| 126255871 | 12625587 | 4 | C | ROHYPNOL | FLUNITRAZEPAM | 1 | UNK | 0 | |||||||||||
| 126255871 | 12625587 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 126255871 | 12625587 | 6 | C | CLOPIDOGREL SULFATE | CLOPIDOGREL BISULFATE | 1 | UNK | 0 | |||||||||||
| 126255871 | 12625587 | 7 | C | CINAL | ASCORBIC ACIDCALCIUM PANTOTHENATE | 1 | UNK | 0 | |||||||||||
| 126255871 | 12625587 | 8 | C | ALLELOCK | OLOPATADINE HYDROCHLORIDE | 1 | 5 MG, BID | 0 | 5 | MG | BID | ||||||||
| 126255871 | 12625587 | 9 | C | MAGMITT | MAGNESIUM OXIDE | 1 | 330 MG, TID | 0 | 330 | MG | TID | ||||||||
| 126255871 | 12625587 | 10 | C | FAMOTIDINE. | FAMOTIDINE | 1 | UNK | 0 | |||||||||||
| 126255871 | 12625587 | 11 | C | SHOFUSAN | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126255871 | 12625587 | 1 | Epilepsy |
| 126255871 | 12625587 | 3 | Epilepsy |
| 126255871 | 12625587 | 8 | Cellulitis |
| 126255871 | 12625587 | 11 | Cellulitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126255871 | 12625587 | OT |
| 126255871 | 12625587 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126255871 | 12625587 | Blister | |
| 126255871 | 12625587 | Dermatitis | |
| 126255871 | 12625587 | Drug eruption | |
| 126255871 | 12625587 | Effusion | |
| 126255871 | 12625587 | Erythema | |
| 126255871 | 12625587 | Erythema of eyelid | |
| 126255871 | 12625587 | Eye discharge | |
| 126255871 | 12625587 | Lip erosion | |
| 126255871 | 12625587 | Ocular hyperaemia | |
| 126255871 | 12625587 | Oral mucosa erosion | |
| 126255871 | 12625587 | Pruritus generalised | |
| 126255871 | 12625587 | Skin erosion | |
| 126255871 | 12625587 | Stevens-Johnson syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126255871 | 12625587 | 1 | 20151224 | 0 | ||
| 126255871 | 12625587 | 2 | 20160204 | 20160330 | 0 | |
| 126255871 | 12625587 | 8 | 2007 | 0 | ||
| 126255871 | 12625587 | 11 | 2007 | 0 |